Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis
about
Recent Insights into Cell Surface Heparan Sulphate Proteoglycans and CancerMechanisms of heparanase inhibitors in cancer therapy.Elevated heparanase expression is associated with poor prognosis in breast cancer: a study based on systematic review and TCGA data.Heparanase 2 Attenuates Head and Neck Tumor Vascularity and Growth.Heparanase is required for activation and function of macrophages.The prognostic significance of heparanase expression in metastatic melanomaNK cell heparanase controls tumor invasion and immune surveillance.Heparanase: a rainbow pharmacological target associated to multiple pathologies including rare diseases.Heparanase: roles in cell survival, extracellular matrix remodelling and the development of kidney disease.Heparanase and cancer progression: New directions, new promises.Chemotherapy induces expression and release of heparanase leading to changes associated with an aggressive tumor phenotype.Gemcitabine-induced heparanase promotes aggressiveness of pancreatic cancer cells via activating EGFR signaling.Heparanase: From basic research to therapeutic applications in cancer and inflammation.Opposing Functions of Heparanase-1 and Heparanase-2 in Cancer Progression.Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior.Microenvironment modulation and enhancement of antilymphoma therapy by the heparanase inhibitor roneparstat.Prognostic significance of heparanase expression in primary and metastatic breast carcinoma.Patient derived xenografts (PDX) predict an effective heparanase-based therapy for lung cancer.Immunomodulatory activities of pixatimod: emerging nonclinical and clinical data, and its potential utility in combination with PD-1 inhibitors.Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
P2860
Q26740617-07B4A16B-54C4-49D4-B636-FDE3A5151229Q30244089-1226CDBF-F44C-489F-89D0-F5ED2C5209E4Q36339725-F203C158-4D82-4F45-91BB-ADB58C241B60Q36917969-0620788F-C447-4A59-BE7A-1052F12E0211Q37473740-6163708A-F3F0-470A-A83A-AB27A042F472Q37688833-D5D9F92B-5D73-4FE3-BA48-0355EDEA661BQ38701256-8764E176-16EA-4C4E-B595-4B6BA3B9BE5BQ38801721-073925AA-A873-4E36-83E1-8118DF94CAFAQ39120713-10D4F075-2265-4086-91E5-24DD2F8BC024Q41118533-3E615D1C-B151-4605-AE8B-A4AC918CE4D1Q41158870-8ACA68D1-E698-4D76-933E-C56F3C045FA2Q41709484-7A1268D8-6217-4F5E-A2DB-7D348AA74BF1Q42587945-C7553075-9345-41A9-88C4-2A019FC76C72Q47377873-B08DE5E8-8A2E-400C-B957-A3F8AB0FA3C2Q48008217-3D751599-1550-4635-9CEF-1A4189746852Q48089220-69ABC247-6E69-45F1-BFB1-567D48176A9BQ49787551-EB5AA967-0E0F-4B5C-9B1C-E7651A49AE5DQ55054468-F8E2A17F-275E-4BAB-AC8B-4992EEECBBE4Q55414494-40897C43-66EC-42AC-8B01-B6393A56A935Q58705289-020CBE62-B7CC-40EA-9C04-EC67B7BA36EF
P2860
Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis
@ast
Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis
@en
type
label
Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis
@ast
Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis
@en
prefLabel
Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis
@ast
Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis
@en
P2093
P2860
P356
P1476
Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis
@en
P2093
Edward Hammond
Gil Arvatz
Inna Naroditsky
Israel Vlodavsky
Marina Weissmann
Netanel Horowitz
P2860
P304
P356
10.1073/PNAS.1519453113
P407
P50
P577
2016-01-04T00:00:00Z